Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02180940

Ligand	Ligand name	Chain	PDB	Tanimoto
DEH	2,9-dihydroxy-3,10-dimethoxy-5,6-dihydroisoquino[3,2-a]isoquinolinium	A	3GSY	0.71
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.74
EUG	2-METHOXY-4-VINYL-PHENOL	A	2QU9	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1QLU	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1W1J	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	2VAO	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1W1K	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1DZN	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1W1L	0.73
EUG	2-METHOXY-4-VINYL-PHENOL	A,B	1W1M	0.73
ESM	1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER	A	1LHW	0.71
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.73
REN	(S)-reticuline	A	3FWA	0.95
REN	(S)-reticuline	A	3D2D	0.95
AAU	(5R,6R)-5-BENZYL-6-HYDROXY-2,4-BIS(4-HYDROXY-3-METHOXYBENZYL)-1-[3-(4-HYDROXYPHENYL)PROPANOYL]-1,2,4-TRIAZEPAN-3-ONE	B	2A4F	0.71
MOI	(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL	H,L	1Q0Y	0.77
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.72
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.76
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.76
DPD		A,B	1QIW	0.76
DPD		A	1QIV	0.76
MDW	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	A	2DDY	0.75
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.72
ALE	L-EPINEPHRINE	A	3PAH	0.7
ALE	L-EPINEPHRINE	A	2HKK	0.7
PTI	2-PHENYL-1-[4-(2-PIPERIDIN-1-YL-ETHOXY)-PHENYL]-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-6-OL	A	1UOM	0.74
CMZ	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	A	2OF0	0.72
A88	(5R,6R)-2,4-BIS-(4-HYDROXY-3-METHOXYBENZYL)-1,5-DIBENZYL-3-OXO-6-HYDROXY-1,2,4-TRIAZACYCLOHEPTANE	A	1PRO	0.74
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.71
GNT	(-)-GALANTHAMINE	A	1DX6	0.79
GNT	(-)-GALANTHAMINE	A	1QTI	0.79
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.79
GNT	(-)-GALANTHAMINE	A,B	1W76	0.79
GNT	(-)-GALANTHAMINE	A	1W6R	0.79
LDP	L-DOPAMINE	A,B	2A3R	0.71
LDP	L-DOPAMINE	A	5PAH	0.71
LDP	L-DOPAMINE	A,B	2QMZ	0.71
LDP	L-DOPAMINE	A,B	2VQ5	0.71
8PS	5-OCTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B37	0.72
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.92
5PP	5-PENTYL-2-PHENOXYPHENOL	A,B,C,D,E,F	2B36	0.72
GVB	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	A,B	2JID	0.72
4CR	(1R)-4-({[ETHYL(METHYL)AMINO]CARBONYL}OXY)-N-METHYL-N-[(1E)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C65	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.74
LO2	2-{4-[butyl(3-chloro-4,5-dimethoxybenzyl)amino]phenyl}-1,1,1,3,3,3-hexafluoropropan-2-ol	A,B,C,D	3FAL	0.71
HV7	1-METHYLAMINE-2-HYDROXY-4-METHOXY-BENZENE	C	1A8G	0.7
MR1	1-(1,3-BENZODIOXOL-5-YL)METHANAMINE	A	2ORQ	0.71